<DOC>
	<DOCNO>NCT00301067</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , temozolomide , work different way stop growth tumor cell , either kill cell stop dividing . Calcitriol may help temozolomide kill tumor cell make sensitive drug . Calcitriol may also stop growth melanoma block blood flow tumor . PURPOSE : This phase I/II trial study best dose calcitriol , side effect calcitriol give together temozolomide , see well work treat patient metastatic stage IV melanoma .</brief_summary>
	<brief_title>Phase I/II Study High-Dose Calcitriol Plus Temodar Patients With Metastatic Melanoma</brief_title>
	<detailed_description>* Phase I : Patients receive oral calcitriol day 1 15 oral temozolomide day 2-8 16-22 . Treatment repeat every 28 day 2 course absence unacceptable toxicity . Responding patient continue therapy 6 course absence unacceptable toxicity . Cohorts 3-6 patient receive escalate dos calcitriol maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 6 patient experience dose limit toxicity . - Phase II : Patients receive temozolomide calcitriol MTD phase I . After completion study treatment , patient follow every 3 month .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Histologically confirm malignant melanoma Any primary tumor site Stage IV disease CNS metastases allow Measurable disease , define least 1 lesion accurately measure least 1 dimension ≥ 20 mm conventional technique OR ≥ 10 mm spiral CT scan Must least 1 prior systemic therapy Negative pregnancy test Fertile patient must use effective contraception Patients prior systemic therapy eligible provide candidate highdose interleukin2 Recovered toxic effect prior therapy More 4 week since prior concurrent radiotherapy , chemotherapy , immunotherapy More 4 week since prior concurrent radiotherapy , chemotherapy , immunotherapy Fertile patient must use effective contraception Life expectancy le 4 month know HIV positivity evidence active infection require antibiotic therapy malignancy within past 5 year except surgically resect basal cell squamous cell skin cancer significant medical disease , opinion investigator , may interfere study completion pregnant nursing Negative pregnancy test prior temozolomide dacarbazine investigational agent within 4 week prior study entry concurrent magnesiumcontaining antacid , digitalis , bileresin binding drug , calcium supplement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>stage IV melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
</DOC>